|
| Know your limits: RPA availability and chemoresistance in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.26607
Emile Fortier, Elliot Drobetsky, and Hugo Wurtele
|
| 800-802 |
|
| Pregnancies in young women with diagnosis and treatment of HER2positive breast cancer |
|
https://doi.org/10.18632/oncotarget.26611
Matteo Lambertini, and Giulia Viglietti
|
| 803-804 |
|
| Antiphospholipid immune complexes as thrombosis risk marker |
|
https://doi.org/10.18632/oncotarget.26612
José A. MartÃnez-Flores, Manuel Serrano, and Antonio Serrano
|
| 805-806 |
|
| Physical activity fragmentation as a potential phenotype of accelerated aging |
|
https://doi.org/10.18632/oncotarget.26631
Amal A. Wanigatunga, Luigi Ferrucci, and Jennifer A. Schrack
|
| 807-809 |
|
| Transforming growth factor βinduced epithelialtomesenchymal signature predicts metastasisfree survival in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26574
Edna Gordian, Eric A. Welsh, Nicholas Gimbrone, Erin M. Siegel, David Shibata, Ben C. Creelan, William Douglas Cress, Steven A. Eschrich, Eric B. Haura, and Teresita Muñoz-Antonia
|
| 810-824 |
|
| Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γirradiation in human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.26582
Vladimir N. Ivanov, Jinhua Wu, Tony J.C. Wang, and Tom K. Hei
|
| 825-846 |
|
| Triplet chemotherapy with docetaxel cisplatin and S1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results |
|
https://doi.org/10.18632/oncotarget.26614
Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, and Hiroki Yamaue
|
| 847-855 |
|
| Enhanced phosphatidylserineselective cancer therapy with irradiation and SapCDOPS nanovesicles |
|
https://doi.org/10.18632/oncotarget.26615
Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Swarajya L. Vallabhapurapu, Robert S. Franco, Michelle Mierzwa, William Kassing, William L. Barrett, and Xiaoyang Qi
|
| 856-868 |
|
| Characterization and dynamics of specific T cells against nucleophosmin1 NPM1mutated peptides in patients with NPM1mutated acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26617
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, Patrizia Barozzi, Daniela Vallerini, Monica Morselli, Ambra Paolini, Paola Bresciani, Elisabetta Colaci, Monica Maccaferri, Andrea Gilioli, Vincenzo Nasillo, Andrea Messerotti, Valeria Pioli, Laura Arletti, Davide Giusti, Francesca Bettelli, Melania Celli, Francesca Donatelli, Giorgia Corradini, Sabrina Basso, Antonella Gurrado, Monica Cellini, Tommaso Trenti, Roberto Marasca, Franco Narni, Maria Paola Martelli, Brunangelo Falini, Leonardo Potenza, Mario Luppi, and Patrizia Comoli
|
| 869-882 |
|
| Oxygen in the tumor microenvironment: effects on dendritic cell function |
|
https://doi.org/10.18632/oncotarget.26608
Laurent M. Paardekooper, Willemijn Vos, and Geert van den Bogaart
|
| 883-896 |
|
| Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosisinducing properties of human enzymes for the selective elimination of tumor cells |
|
https://doi.org/10.18632/oncotarget.26618
Neelakshi Mungra, Sandra Jordaan, Precious Hlongwane, Krupa Naran, Shivan Chetty, and Stefan Barth
|
| 897-915 |
|
| Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers |
|
https://doi.org/10.18632/oncotarget.26649
Nuša Trošt, Samuel Peña-Llopis, Sajjan Koirala, Jurij Stojan, Patrick Ryan Potts, Klementina Fon Tacer, and Elisabeth D. Martinez
|
| 916-916 |
|
| Correction: The prognostic significance of combined androgen receptor ECadherin Ki67 and CK5/6 expression in patients with triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26650
Barbara Adamo, Giuseppina Rosaria Rita Ricciardi, Antonio Ieni, Tindara Franchina, Carmine Fazzari, Maria Vita Sanò, Giuseppe Angelico, Michele Caruso, Giovanni Tuccari, and Vincenzo Adamo
|
| 917-917 |
